International Cannabis Weekly: 151

• Cannabis beverage market projected to hit US$1.82 billion by year end.
• US Congressman calls for drug decriminalisation in new policing reform plan.
• Professors Mike Barnes and David Nutt release extensive review on UK cannabis policy.

• The Netherlands to begin accepting cultivation applications from next month.
• French cannabis startup raises US$1.13 million to launch two new brands.
• The Netherlands appears to be limiting exports to German wholesalers.
• Deadline to apply for German cannabis distribution contract extended for a third time.
• Calls for cannabis legalisation in Spain as post-COVID recession nears.
• First Irish-based cannabis fund launches in Dublin.

The Disrupting Drinks report aims to equip you with the tools to analyse the rapidly emerging cannabis and CBD drinks market, providing you with the latest proprietary consumer research, competitor analysis, trend forecasts and commercial opportunities.

BUY NOW

• Columbia Care sued for US$50 million over alleged fraudulent licensing scheme.
• Iowa Senate passes controversial medical cannabis bill reducing allowable THC content.
• Acreage Holdings pulls out of Iowa medical cannabis market.
• Nebraska cannabis legalisation campaign delivers nearly 50,000 petition signatures.
• Multiplatinum artist Kelis to present at Prohibition Partners LIVE.

• Canadian businesses exported a record amount of dried cannabis in 2019.
• Organigram enters 3,000-kilo cannabis supply agreement with Israeli firm Canndoc.
• New lawsuit alleges Tilray execs misled investors and engaged in insider stock sales.
• Labelling errors see Alberta issue Canada’s first cannabis beverage recall.
• Bonify resumes selling cannabis in Canada after licence suspension.

This is not another webinar! Prohibition Partners LIVE grants you unparalleled access to the global cannabis industry, connecting you with the most influential network in the industry. Grow your business, build your profile and shape the future of cannabis.

One single ticket gives you access to five virtual stages, thousands of expert delegates and over 120 hours of insights. All for $129 (£102).

BUY TICKETS NOW

• Bermuda seeks public feedback on cannabis legalisation proposal.
• Work begins on Peru’s first medicinal cannabis pharmacy chain.
• Cannabis could tackle economic recession in Latin America, says Uruguayan professor.
• Uruguay plans to become the world’s largest exporter of medical cannabis in 2020.

• NSW data shows indigenous people disproportionately prosecuted for cannabis.
• NZ advertising authority receives complaints over Drug Foundations’ referendum adverts.
• Auckland University of Technology will offer a course on medicinal cannabis from July.
• Medical cannabis firm Equalis endorses voting ‘no’ in upcoming cannabis referendum.

• Israeli government announces plan to advance cannabis legalisation reforms.
• Malawian firms are still awaiting implementation of new cannabis farming laws.
• Wuhan General Group signs distribution agreement with Medigrow Africa.
• Panaxia Israel announces receipt of EU-GMP certification, advancing EU export efforts.

• Study concludes inaccuracies in CBD product labelling ‘appear to be the norm’.
• No evidence cannabis legalisation impacts adolescent use, finds study.
• CBD shows potential in treating psychiatric and neurologic conditions.

• Potential of psychedelics in treating depression cannot be ignored, says top professor.
• Terminally ill Canadians appeal to the health minister for compassionate psilocybin use.
• Numinus amends Health Canada licence to produce and extract psilocybin.
• Mydecine Innovations Group to acquire NeuroPharm Inc.
• Cambridge scientists identify brain phenomena that may explain ketamine side effects.